The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
 
Chun-Ming Tsai
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Lilly; MSD Oncology; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG
Research Funding - AstraZeneca
 
Chun-Liang Lai
No Relationships to Disclose
 
Chao-Hua Chiu
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Roche Pharma AG
 
Te-Chun Hsia
No Relationships to Disclose
 
Chen-Hsin Chen
No Relationships to Disclose
 
Gee-Chen Chang
No Relationships to Disclose
 
Jin-Yuan Shih
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; Roche Pharma AG
Research Funding - GlaxoSmithKline
 
Ching-Liang Ho
No Relationships to Disclose
 
Yuh-Min Chen
No Relationships to Disclose
 
James Chih-Hsin Yang
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Merck; MSD; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Boehringer Ingelheim